Breaking: We Just Caught Another Interesting Trade. President Donald Trump Filed A March 4th Purchase Of Stock In Corcept Therapeutics, $Cort It's A Pharmaceutical Company. On March 25th, The Fda Approved Corcept's Drug Lifyorli. The Stock Has Now Risen 153% Since March 4th.